Study S001279

Emulation of the Effects of Oral Semaglutide on Cardiovascular Outcomes in Individuals With Type 2 Diabetes: PIONEER6 Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT06659679
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 26126
Start: 2024-10-24
Primary completion: 2025-03-06
Lead sponsor: Brigham and Women's Hospital
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:New use of oral semaglutide; DRUG:New initiation of sitagliptin
Results posted: FALSE

Registered primary outcomes

Major adverse cardiac event (MACE), including myocardial infarction, stroke, and all cause death [Through study completion (1 day after cohort entry date until the first of outcome or censoring)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.